Walter van der Velden

10PUBLICATIONS
46CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AudiologyHaematological tumoursHaematologyImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Feb 27, 2025
Correction: Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002.

Gabrielle Meyers, Mehdi Hamadani, Michael Martens

|Apr 29, 2024
Benefits and risks of clofarabine in adult acute lymphoblastic leukemia investigated in depth by multi-state modeling.

Sjoerd J F Hermans, Yvette van Norden, Jurjen Versluis

|Sep 25, 2023
Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002.

Gabrielle Meyers, Mehdi Hamadani, Michael Martens

|Aug 22, 2023
Predictors of the corrected count increment after platelet transfusion, a secondary analysis of the PACER randomized controlled trial.

Floor L F van Baarle, Emma K van de Weerdt, Walter J F M van der Velden

|Jun 06, 2022
Grading bloodstream infection risk using citrulline as a biomarker of intestinal mucositis in patients receiving intensive therapy.

C E M de Mooij, W J F M van der Velden, A F J de Haan

Pageof 2